— Know what they know.
Not Investment Advice
Also trades as: RYM.NZ (NZE) · $vol 2M · RYHTY (OTC) · $vol 0M

RHCGF Earnings

Ryman Healthcare Limited
1W: +0.0% 1M: -24.3% 3M: +3.7% YTD: -36.0% 1Y: -21.7% 3Y: -69.1% 5Y: -87.0%
$1.12
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Care Facilities · Tech Score Strong Sell · Power 35 · $1.1B mcap · 948M float · 0.0000% daily turnover · Short 100% of daily vol
Last Earnings 2025-11-25
EPS
NZ$-0.03 (US$-0.01)
▼ Miss +0.0%
Revenue
NZ$225M ($127M)
▼ Miss -2.6%
Next Earnings 2026-11-20
EPS Estimate
NZ$0.02 (US$0.01)
Revenue Estimate
NZ$278M ($156M)
1 USD = 1.78 NZD

Estimate vs Actual

Earnings Surprise History

5/16
EPS Beats
2/16
Revenue Beats
31%
EPS Beat Rate
12%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-10-02 annual 2027-03-31 NZ$0.04 NZ$0.04 — NZ$526,842,683 NZ$526,366,156
2026-10-02 annual 2031-03-31 NZ$— NZ$— — NZ$617,415,750 NZ$616,857,299
2026-10-02 annual 2030-03-31 NZ$— NZ$— — NZ$594,297,899 NZ$593,760,360
2026-10-02 annual 2029-03-31 NZ$0.10 NZ$0.10 — NZ$603,290,885 NZ$602,745,211
2026-10-02 annual 2028-03-31 NZ$0.07 NZ$0.07 — NZ$567,675,670 NZ$567,162,210
2026-10-01 annual 2031-03-31 NZ$— NZ$— — NZ$619,222,500 NZ$617,415,750
2026-10-01 annual 2030-03-31 NZ$— NZ$— — NZ$596,037,000 NZ$594,297,899
2026-10-01 annual 2028-03-31 NZ$0.07 NZ$0.07 — NZ$569,331,693 NZ$567,675,670
2026-10-01 annual 2027-03-31 NZ$0.04 NZ$0.04 — NZ$528,384,812 NZ$526,842,683
2026-10-01 annual 2029-03-31 NZ$0.10 NZ$0.10 — NZ$605,056,301 NZ$603,290,885
2026-09-29 annual 2028-03-31 NZ$0.07 NZ$0.07 — NZ$569,593,455 NZ$569,331,693
2026-09-29 annual 2027-03-31 NZ$0.04 NZ$0.04 — NZ$528,627,748 NZ$528,384,812
2026-09-29 annual 2029-03-31 NZ$0.10 NZ$0.10 — NZ$605,334,488 NZ$605,056,301
2026-09-29 annual 2031-03-31 NZ$— NZ$— — NZ$619,507,200 NZ$619,222,500
2026-09-29 annual 2030-03-31 NZ$— NZ$— — NZ$596,311,040 NZ$596,037,000
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms